Latest News : 2014 : August

Rong Wen, M.D., Ph.D.

Bascom Palmer Licenses Retinal Disorder Product to Biotech Company

In a deal that may lead to the first viable treatment for retinal diseases, Amarantus Bioscience Holdings, Inc., a biotechnology company, has exercised its exclusive right to license intellectual property related to a protein product developed by a researcher at the Miller School of Medicine’s Bascom Palmer Eye Institute.

Read more »

From left, FTRP grant recipients Glen Barber, Ph.D.; Shaun Brothers, Ph.D.; Claes Wahlestedt, M.D., Ph.D.; Seung-Uon Shin, Ph.D.; and Joseph Rosenblatt, M.D.

Miller School Researchers Receive State Funding for Drug-Discovery Projects

Miller School of Medicine researchers have received three grants in the latest round of funding from the Florida Translational Research Program (FTRP), a state-funded initiative to advance drug discovery. All of the projects receiving awards focus on the discovery and development of novel small molecules for the treatment of disease, specifically cancer.

Read more »